Maker of Blood Alcohol Content Apps Settles with FTC
A company that develops and manufactures smartphone apps designed to measure consumer blood alcohol content (BAC) and help people determine if they are able to drive safely after drinking alcohol, has agreed to settle with the Federal Trade Commission (FTC) over charges that scientific evidence supporting its advertising claims is lacking.
According to an FTC press release, Breathometer, Inc. is prohibited from making future claims about its consumer breathalyzer products—Original and Breeze—unless the claims are backed by comprehensive testing. The FTC also reports that the company is required to notify consumers who purchased the devices that they may be inaccurate and to provide full refunds.
Breathometer received funding for its product after successfully pitching its consumer breathalyzer to investors on the television show "Shark Tank." According to the FTC, the company's claim that the accuracy of its devices was proven through "government-lab grade testing" was deceptively overstated and dangerous.
Image Credit: Thinkstock